Sarah Boyce, President and CEO: Avidity Biosciences RNA Sell · Filed 01/23

Trade details

Type: Insider sale
Amount: $579,092.85
Shares · price: 7,993 sh · $72.45 a share
Held after: 269,007 sh
Stock: Avidity Biosciences RNA
Person: Sarah BoycePresident and CEO
Trade date: 26/01/21
Filed: 26/01/23
Days to filing: 2 days

Sold 2.9% of holdings

Share of holding sold: 2.9%

Avidity Biosciences trades, last 26 weeks

What else happened in Avidity Biosciences around then

Filed or reported within 30 days of the trade day · 25/12/22~02/20

Sarah Boyce's recent trades

Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$463.2K
6,394 sh
$463.2K
Filed 01/23
Traded 01/21
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$619.4K
8,576 sh
$619.4K
Filed 01/09
Traded 01/07
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$2.5M
50,000 sh
$2.5M
Filed 25/09/05
Traded 25/09/05
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$1.2M
25,000 sh
$1.2M
Filed 25/08/29
Traded 25/08/28
Sarah BoycePresident and CEO
Sell10b5-1 planAvidity Biosciences
Sell10b5-1 plan
Avidity Biosciences
RNA
$979.6K
31,540 sh
$979.6K
Filed 25/03/21
Traded 25/03/20

Sarah Boyce, CEO — sold $579.1K of Avidity Biosciences RNA · 2.9% of holdings · 10b5-1 plan | Whalegun